MAOIlääkevalikoima
MAOIlääkevalikoima refers to the range of available monoamine oxidase inhibitor (MAOI) medications. MAOIs are a class of antidepressants that work by inhibiting the activity of monoamine oxidase enzymes, which are responsible for breaking down neurotransmitters like serotonin, norepinephrine, and dopamine. By increasing the levels of these neurotransmitters in the brain, MAOIs can help alleviate symptoms of depression and other mood disorders.
Historically, MAOIs were among the first antidepressants developed. The selection of MAOIs has evolved over time,
The MAOIlääkevalikoima typically includes medications like phenelzine, tranylcypromine, isocarboxazid, and selegiline. Selegiline, in particular, is also